Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2006
View Archived Issues
BioMarin updates recent pipeline highlights
Read More
PamGene's 3D flow-through microarray technology useful for drug screening
Read More
AMD-070 is active in HIV patients
Read More
MorphoSys and Daiichi Sankyo establish antibody collaboration
Read More
Targeted Genetics amends phase I study of tgAAC94
Read More
Wyeth discontinues phase III breast cancer study of oral temsirolimus
Read More
Positive phase I results for Stem Cell Therapeutics NTx-265 program
Read More
Xcyte Therapies stock holders approve transaction with Cyclacel
Read More
Inex to license three targeted chemotherapy products to Hana Biosciences
Read More
Actavis makes approach to acquire Pliva
Read More
Additional clinical data not required for approval of Seasonique
Read More
Phase II ovarian cancer study of AS-1404 completes enrollment
Read More
Femara approved for new indication in Germany
Read More
PMA filed for Durolane
Read More
Orphan drug status for Ceflatonin in CML
Read More
Genentech provides brief business overview
Read More
Avantogen and Hawaii Biotech to combine vaccine businesses
Read More
Rituximab to be studied for type 1 diabetes
Read More
N-Acetylcysteine as a potential treatment for cystic fibrosis
Read More
Candesartan used to successfully treat prehypertension
Read More
Valproic acid may ameliorate HIV-associated cognitive impairment
Read More
Entecavir superior to lamivudine in HBeAg-positive and -negative hepatitis B
Read More
EG-S21 studied for Crohn's disease in new phase II trial
Read More
YM-359445: orally active VEGFR2 TK inhibitor with potent antitumor activity
Read More
Novel urological agents disclosed in recent patent literature
Read More
PPARgamma agonists claimed in Galderma patent for skin disorders
Read More
Antitumor efficacy of titanocene Y presented
Read More
New agents for use in cardiovascular disease treatment revealed in Wyeth and Ferring patents
Read More
Portuguese scientists identify two novel synthetic aromatase inhibitors
Read More
Conjugation of methotrexate to mannan improves antitumor activity in vivo
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe